Literature DB >> 34866311

Recommended scoring approach for the pediatric patient-reported outcomes version of the Common Terminology Criteria for Adverse Events.

Pamela S Hinds1,2, Laura C Pinheiro3, Molly McFatrich4, Mia Waldron1,2, Justin N Baker5, Catriona Mowbray1, Scott H Maurer6, Yao Cheng1, Bryce B Reeve4, Jichuan Wang1,2.   

Abstract

BACKGROUND: Collecting symptom, function, and adverse event (AE) data directly from children and adolescents undergoing cancer care is more comprehensive and accurate than relying solely on their caregivers or clinicians for their interpretations. We developed the pediatric patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE) measurement system with input from children, parents, and clinicians. Here, we report how we determined the recommended Ped-PRO-CTCAE item scoring approach.
METHODS: Data from 271 patients were analyzed using three scoring approaches: (a) at the AE attribute (frequency, severity, interference) using ordinal and dichotomous measures; (b) a weighted composite AE item score by AE attribute (0.5 - frequency; 1.0 - severity; 1.5 - interference); and (c) overall number of AEs endorsed. Associations of each AE attribute, AE item score, and overall AE score with the Patient-Reported Outcome Measurement Information System (PROMIS) Pediatric measures were examined. The ability of the overall Ped-PRO-CTCAE AE score to identify patients with PROMIS symptom T-scores worse than reference population scores was assessed. Clinician preference for score information display was elicited through interviews with five pediatric oncology clinical trialists.
RESULTS: The diverse scoring approaches yielded similar outcomes, including positive correlations of the Ped-PRO-CTCAE attributes, AE item score, and the overall AEs score with the PROMIS Pediatric measures. Clinicians preferred the most granular display of scoring information (actual score reported by the child and corresponding descriptive term).
CONCLUSIONS: Although three scoring approaches yielded similar results, we recommend the AE attribute level of one score per Ped-PRO-CTCAE AE attribute for its simplicity of use in care and research.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  adverse events; cancer; patient-reported outcomes; pediatrics; scoring

Mesh:

Year:  2021        PMID: 34866311      PMCID: PMC9038621          DOI: 10.1002/pbc.29452

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.838


  42 in total

1.  Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Authors:  Amylou C Dueck; Tito R Mendoza; Sandra A Mitchell; Bryce B Reeve; Kathleen M Castro; Lauren J Rogak; Thomas M Atkinson; Antonia V Bennett; Andrea M Denicoff; Ann M O'Mara; Yuelin Li; Steven B Clauser; Donna M Bryant; James D Bearden; Theresa A Gillis; Jay K Harness; Robert D Siegel; Diane B Paul; Charles S Cleeland; Deborah Schrag; Jeff A Sloan; Amy P Abernethy; Deborah W Bruner; Lori M Minasian; Ethan Basch
Journal:  JAMA Oncol       Date:  2015-11       Impact factor: 31.777

2.  Long-term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study.

Authors:  Daniel J Zheng; Kevin R Krull; Yan Chen; Lisa Diller; Yutaka Yasui; Wendy Leisenring; Pim Brouwers; Rebecca Howell; Jin-Shei Lai; Lyn Balsamo; Kevin C Oeffinger; Leslie L Robison; Gregory T Armstrong; Nina S Kadan-Lottick
Journal:  Cancer       Date:  2018-06-11       Impact factor: 6.860

3.  Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Authors:  Helle Pappot; Christina Baeksted; Ann Knoop; Sandra A Mitchell; Aase Nissen; Christoffer Johansen
Journal:  Breast J       Date:  2019-02-13       Impact factor: 2.431

Review 4.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

Authors:  M H Zweig; G Campbell
Journal:  Clin Chem       Date:  1993-04       Impact factor: 8.327

5.  Comparison of Legacy Fatigue Measures With the PROMIS Pediatric Fatigue Short Form
.

Authors:  Catherine F Macpherson; Jichuan Wang; Darren A DeWalt; Emily D Stern; Shana Jacobs; Pamela S Hinds
Journal:  Oncol Nurs Forum       Date:  2018-01-01       Impact factor: 2.172

6.  Systematic Symptom Reporting by Pediatric Palliative Care Patients with Cancer: A Preliminary Report.

Authors:  Kevin Madden; Maira Magno Charone; Sarah Mills; Seyedeh Dibaj; Janet L Williams; Diane Liu; Eduardo Bruera
Journal:  J Palliat Med       Date:  2019-02-13       Impact factor: 2.947

7.  PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions.

Authors:  Darren A DeWalt; Heather E Gross; Debbie S Gipson; David T Selewski; Esi Morgan DeWitt; Carlton D Dampier; Pamela S Hinds; I-Chan Huang; David Thissen; James W Varni
Journal:  Qual Life Res       Date:  2015-02-26       Impact factor: 4.147

8.  Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Library.

Authors:  Daniel Shepshelovich; Kate McDonald; Anna Spreafico; Albiruni R A Razak; Philippe L Bedard; Lillian L Siu; Lori Minasian; Aaron R Hansen
Journal:  Oncologist       Date:  2019-02-06

Review 9.  Parent-child agreement across child health-related quality of life instruments: a review of the literature.

Authors:  Penney Upton; Joanne Lawford; Christine Eiser
Journal:  Qual Life Res       Date:  2008-06-03       Impact factor: 4.147

10.  Child symptoms, parent behaviors, and family strain in long-term survivors of childhood acute lymphoblastic leukemia.

Authors:  I-Chan Huang; Tara M Brinkman; Larry Mullins; Ching-Hon Pui; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Psychooncology       Date:  2018-06-29       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.